Concepedia

Chantal Dreyer

CD

Statistics

Publications

17

Citations

775

H-Index

16

Active since

1997

Affiliations

Hôpital Beaujon(Current)

Université Paris Cité

Assistance Publique – Hôpitaux de Paris

Institut Gustave Roussy

Inserm

Chantal Dreyer is an author at Hôpital Beaujon specializing in medicine, oncology, and cancer pharmacology.

Publications per year

1997–2022

17

Publications

17

Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Maxime Ronot, Mohamed Bouattour, Johanna Wassermann et al. · The Oncologist · 2014 · 156 citations · Full text

, , +17

Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib

Sandrine Faivre, Magaly Zappa, Valérie Vilgrain et al. · Clinical Cancer Research · 2011 · 90 citations

, , +16

Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin.

Markus S. Schwab, Chantal Dreyer · PubMed · 1997 · 72 citations

, , +5

Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms

Anna Pellat, Chantal Dreyer, Camille Couffignal et al. · Neuroendocrinology · 2018 · 59 citations

, , +17

Incidence of injuries in the New Zealand national rugby league sevens tournament

Doug King, Tim J. Gabbett, Chantal Dreyer et al. · Journal of science and medicine in sport · 2006 · 55 citations

, , +8

1–5 of 17